Zobrazeno 1 - 10
of 19 738
pro vyhledávání: '"non‐Hodgkin lymphoma"'
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 4501-4510 (2024)
Ya-Qing Lin,1 Na Li,2 Yan-Li Wu,1 Jin-Bao Ma,3 Hai-Nv Gao,1 Xuan Zhang4 1Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan (Hangzhou) Hospital Affiliated to Shulan International Medical College, Zhejiang Shur
Externí odkaz:
https://doaj.org/article/fd9867818dbb478d9d50c1d974e72067
Autor:
Hai-Chao Tong, Shuang Ma, Lan Chen, Xiangyun Meng, Ying-Chun Li, Le-Yao Li, Lingyun Dong, Wan-Lin Zhang, Tyler Wildes, Lian-He Yang, Endi Wang
Publikováno v:
Diagnostic Pathology, Vol 19, Iss 1, Pp 1-7 (2024)
Abstract Rationale Warthin tumor (WT) is the second most common benign tumor in salivary gland. It has a slow growth rate and most frequently occurs in the parotid gland. Most patients present with an incidental finding of a painless mass inferior/an
Externí odkaz:
https://doaj.org/article/eb7853c118474a85a3b308ce439e0c29
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Non-Hodgkin lymphoma (NHL) has been identified as a significant contributor to the cancer burden. This study investigates the incidence, mortality, and survival trends of NHL cancer in Brunei Darussalam from 2011 to 2020. Methods
Externí odkaz:
https://doaj.org/article/de5e20c17f5a4b4e847bb1615be3d84d
Autor:
Allison Rosenthal, Javier Munoz, Monika Jun, Tongsheng Wang, Alex Mutebi, Anthony Wang, Shibing Yang, Kojo Osei-Bonsu, Brian Elliott, Fernando Rivas Navarro, Junhua Yu, Samantha Brodkin, Mariana Sacchi, Andrew Ip
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-5 (2024)
Abstract Many therapies are available for the treatment of relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) after ≥ 2 lines of therapy, albeit with scant evidence on the comparative effectiveness of these therapies. This study used i
Externí odkaz:
https://doaj.org/article/e75a738adf2847b3ace1b34ecd6f5b70
Autor:
Oehadian A, Kartikasari A, Mersiana L, Gunadi SV, Fungani G, Vidyaniati P, Prasetya D, Wijaya I, Fianza PI, Fadjari TH, Sutedjo NN
Publikováno v:
Journal of Blood Medicine, Vol Volume 15, Pp 341-349 (2024)
Amaylia Oehadian,1 Andini Kartikasari,2 Lusi Mersiana,1 Stephanie Victoria Gunadi,3 Gusti Fungani,1 Putri Vidyaniati,1 Dimmy Prasetya,1 Indra Wijaya,1 Pandji Irani Fianza,1 Trinugroho Heri Fadjari,1 Nanny Natalia Sutedjo4 1Division of Hematology and
Externí odkaz:
https://doaj.org/article/f3009a2b69f34001867abb41e113f8f2
Autor:
Irina V. Poddubnaya, Lali G. Babicheva
Publikováno v:
Современная онкология, Vol 26, Iss 2, Pp 140-148 (2024)
Background. Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of hematological malignancies, the vast majority of which are B-cell tumors. The most common variant of NHL is diffuse large B-cell lymphoma (DLBCL), characterized by an aggressive c
Externí odkaz:
https://doaj.org/article/451bfc2dfc7241a99a818c6b5ea80db3
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-6 (2024)
Abstract Background Membranous nephropathy (MN) is a common type of nephrotic syndrome (NS) in adults, accounting for about 20–30% of cases. Although secondary to specific factors, the coexistence of MN and mantle cell lymphoma (MCL) has been scarc
Externí odkaz:
https://doaj.org/article/a60081b3258e432bb1ee37c44b114333
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-5 (2024)
Abstract Background Lymphoid neoplasm is a common disease, arising from lymphoid cells. It is divided into Hodgkin lymphoma and non-Hodgkin lymphoma. Non-Hodgkin lymphoma can be intranodular or extranodular, which happens in 25% of primary cases. The
Externí odkaz:
https://doaj.org/article/3ab886aed5114eb8bee7a4bcfd48c2a7
Autor:
Mehdi Bakhtiyaridovvombaygi, Somayeh Yazdanparast, Setare Kheyrandish, Seyed Mehrab Safdari, Fateme Amiri Samani, Mahsa Sohani, Akram Sadat Jaafarian, Fateme Damirchiloo, Amirhossein Izadpanah, Sahar Parkhideh, Fatemeh Mikanik, Elham Roshandel, Abbas Hajifathali, Ahmad Gharehbaghian
Publikováno v:
Biomarker Research, Vol 12, Iss 1, Pp 1-44 (2024)
Abstract Non-Hodgkin lymphomas (NHLs) are heterogeneous and are among the most common hematological malignancies worldwide. Despite the advances in the treatment of patients with NHLs, relapse or resistance to treatment is anticipated in several pati
Externí odkaz:
https://doaj.org/article/3a0a338346264057a589263ac2d40f6e
Publikováno v:
Biomedical Papers, Vol 168, Iss 2, Pp 167-176 (2024)
Background. RTX, an anti-CD20 monoclonal antibody, added to chemotherapy has proven to be effective in children and adolescents with high-grade, high-risk and matured non-Hodgkin lymphoma. RTX leads to prompt CD19+ B lymphocyte depletion. However, de
Externí odkaz:
https://doaj.org/article/12e3a8a9174d4c269d0e5e672ef1062d